Group One Trading, L.P. Otonomy, Inc. Transaction History

Group One Trading, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.25 - $2.24 $1,910 - $17,113	-7,640 Reduced 15.71%	40,981 $12,000
Q2 2022 Aug 11, 2022	BUY	$1.72 - $2.51 $83,628 - $122,038	48,621 New	48,621 $101,000
Q4 2021 Feb 11, 2022	SELL	$1.69 - $2.31 $33,769 - $46,158	-19,982 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.22 - $2.2 $66,011 - $119,037	-54,108 Reduced 73.03%	19,982 $38,000
Q2 2021 Aug 10, 2021	SELL	$2.06 - $2.67 $132,039 - $171,138	-64,097 Reduced 46.38%	74,090 $165,000
Q1 2021 May 12, 2021	BUY	$2.49 - $6.23 $293,374 - $734,024	117,821 Added 578.52%	138,187 $352,000
Q4 2020 Feb 10, 2021	BUY	$3.48 - $6.47 $70,873 - $131,768	20,366 New	20,366 $132,000
Q3 2020 Nov 12, 2020	SELL	$3.16 - $4.36 $122,860 - $169,516	-38,880 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.87 - $3.84 $26,419 - $54,251	14,128 Added 57.08%	38,880 $141,000
Q1 2020 May 13, 2020	BUY	$1.58 - $4.06 $39,108 - $100,493	24,752 New	24,752 $49,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $14,800 - $19,000	-4,000 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$4.05 - $6.1 $39,523 - $59,529	-9,759 Reduced 70.93%	4,000 $17,000
Q4 2017 Feb 09, 2018	SELL	$2.8 - $5.55 $36,369 - $72,088	-12,989 Reduced 48.56%	13,759 $76,000
Q3 2017 Nov 15, 2017	BUY	$3.2 - $20.8 $85,593 - $556,358	26,748	26,748 $87,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.